Mechanisms of Hypoxic Regulation of Plasminogen Activator Inhibitor-1 Gene Expression in Keloid Fibroblasts

Journal of Investigative Dermatology

Volumn 121, Issue 5, 2003, Pages 1005-1012

  Zhang, Qunzhou ^a   Wu, Yidi ^a   Ann, David K ^b   Messadi, Diana V ^c   Tuan, Tai Lan ^b   Kelly, A Paul ^a   Bertolami, Charles N ^d   Le, Anh D ^a,c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antisense; Desferroxamine; Half life; HIF 1 ; Hypoxia

Indexed keywords

DEFEROXAMINE; IRON DERIVATIVE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; KELOID; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; SKIN CULTURE; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 0242406744     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12564.x     Document Type: Article

References (49)

1. Akimoto S, Ishikawa O, Iijima C, Miyachi Y: Expression of basic fibroblast growth factor and its receptor by fibroblasts, macrophages and mast cells in hypertrophic scars. Eur J Dermatol 9:357-362, 1999
2. Andreasen PA, George B, Lund LR, Ruccio A, Stacey SN: Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocriml 68:1-19, 1990
3. Appleton I, Brown NJ, Willoughby DA: Apopstosis, necrosis, and proliferation: Possible implications in the etiology of keloids. Am J Pathol 149:1441-1447, 1996
4. Banfi C, Eriksson P, Giandomenico G, Mussoni M, Sironi L, Hamsten A, Tremoli E. Transcriptional regulation of plasminogen activator inhibitor type-1 gene by insulin. Diabetes 50:1522-1530, 2001
5. Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ: Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin-1. J Clin Invest 78:587-591, 1986
6. Blackburn WR, Cosman C: Histological basis of keloid and hypertrophic scar differentiation. Arch Pathol 82:65-71, 1966
7. Busso N, Niccodeme E, Chesne C, Guillouzo A, Belin D. Hyafil F: Urokinase and type 1 plasminogen activator inhibitor production by normal human hepatocytes: Modulation by inflammatory agents. Hepatology 20:186-190. 1994
8. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M: Hypoxia-induciblc factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF beta (3). J Clin Invest 105: 577-587, 2000
9. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
10. Crossman DC, Carr DP, Tuddenham EG, Pearson JD, McVey JH: The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 265:9782-9787, 1990
11. Crutchley DJ, Conanan LB: Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. J Biol Chem 261: 154-159, 1986
12. Descheemaeker KA, Wyns S, Nelles L, Auwerx J, Ny T, Collen D: Interaction of Ap-1, Ap-2 and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myrisate 13-acetate response. J Biol Chem 267:15086-15091, 1992
13. Ehrlich HP, Desmoulière A, Diegelmann RF, et al: Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105-113, 1994
14. Eitzman DT, McCoy RD, Zheng X, et al: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or over express the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232-237, 1996
15. Erickson LA, Heckman CM, Loskutoff DJ: The primary plaminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. Proc Natl Acad Sci USA 82:8710-8716, 1985
16. Fattal PG, Schneider DJ, Sobel BE, Billadello JJ: Post-transcriptional regulation of expression of plasminogen activator inhibitor-1 mRNA by insulin and insulin like growth factor-1. J Biol Chem 267:12412-12415, 1992
17. Feener EP, Northrup JM, Aiello LP, King GL: Angiotensm II induces plasminogen activator inhibitor-1 and plasminogen activator inhibitor-2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 95:1353-1362, 1995
18. Fink T, Ebbesen P, Zachar V: Quantitative gene expression profiles of human liver-derived cell lines exposed to moderate hypoxia. Cell Physiol Biochem 11:105-114, 2001
19. Fink T, Kazlauskas A, Poellinger L, Ebbesen P, Zachar V: Identification of a tightly regulated hypoxia-response clement in the promoter of human plasminogen activator inhibitor-1. Blood 99:2077-2083, 2002
20. Fitzpatrick TE, Graham CH: Stimulation of plasminogen activator inhobitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp Cell Res 245:155-162, 1998
21. Guppy M: The hypoxic core: A possible answer to the cancer paradox. Biochem Biophys Res Commun 299:676-680, 2002
22. Hasegawa T, Sorensen L, Hidemi O, Marshall BC: Decreased intracellular iron availability suppresses epithelial cell surface plasmin generation: Transcriptional and post-transcriptional effects on u-PA and PAI-1 expression. Am J Respir Cell Mol Biol 21:275-282, 1999
23. Higgins PJ, Slack JK, Diegelmann RF, Staiano-Coico L: Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibric phenotype. Exp Cell Res 248:634-642, 1999
24. Huang EL, Bunn HF: Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 278:19575-19578, 2003
25. Kietzmann T, Roth U, Jungermann K: Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94:4177-4185, 1999
26. Kischer CW: The microvessels in hypertrophic scars, keloids and related lesions: A review. J Submicrosc Cytol Pathol 24:281-296, 1992
27. Kischer CW, Thies AC, Chvapil M: Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 13:819-824, 1982
28. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT: Expression of transforming growth factor beta1, 2, and 3 proteins in keloids. Ann Plast Surg 3:179-184, 1999
29. Messadi DV, Le A, Berg S, Jewett A, Zhuang W, Kelly P, Bertolami CN: Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Rep Reg 7:511-517, 1999
30. Niessen FB, Spauwen PHM, Schalkwijk J, Kon M: On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg 104:1435-1458, 1999
31. Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen JX, Carmeliet P, Loskutoff DJ: Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102:919-928, 1998
32. Reilly CF, McFall RC: Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator-1 synthesis in vascular smooth muscle cells. J Biol Chem 266:9419-9427, 1991
33. Sawdey MS, Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: Tissue specificity and induction by lipopolysacchrides, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88:1346-1353, 1991
34. Scarpati EM, Sadler JE: Regulation of endothelial cells coagulant properties: Modulation of tissue factor, plasminogen activator inhibitors and thrombomodulin by phorbol 12-myristate 13-acetate and TNF. J Biol Chem 264:20705-20713, 1989
35. Semenza GL: Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64:993-998, 2002
36. Shabsigh A, Ghafar MA, Alexandre T, Burchardt M, Kaplan SA, Anastasiadis AG, Buttyan R: Biomarker analysis demonstrates a hypoxic environment in castrated rat ventral prostate gland. J Cell Biochem 81:437-444, 2001
37. Shaw G, Kamen R: A conserved AU sequence from 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degeneration. Cell 46:659-667, 1986
38. Shetty S, Idell S: Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro. Am J Physiol Lung Cell Mol Physiol 278:L148-L156, 2000
39. Shi RJ, Haidaris PJS, Marder VJ, Silverman DJ, Sporn LA: Post-transcriptional regulation of endothelial cell plasminogen activator inhibitor-1 expression during R.rickettsii infection. Microbial Pathogenesis 28:127-133, 2000
40. Song CZ, Siok TE, Gelehrter TD: Smad4/DPC4 and Smad3 mediate transforming growth factor-α (TGF-α) signaling through direct binding to a novel TGF-α-responsive element in the human plasminogen activator inhibitor-1 promoter. J Biol Chem 273:29287-29290, 1998
41. Stiehl DP, Jelkmann W, Wenger RH, Hellwig-Bürgel T: Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1α involves the phosphatidylino sitol 3-kinase pathway. FEBS Lett 512:157-162, 2002
42. Takeda K, Ichiki T, Tokunou T, et al: Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor-1 gene expression. Arterioscler Thromb Vasc Biol 21:868-873, 2001
43. Thorens B, Mermod JJ, Vassalli P: Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell 48:671-679, 1987
44. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE: Increased PAI-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106:1007-1011, 1996
45. Uchiyama T, Kurabayashi M, Ohyama Y, et al: Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 20:1155-1161, 2000
46. Xue H, McCauley RL, Zhang W: Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 89:74-77, 2000
47. Yamamoto K, Saito H: A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders. Int J Hematol 68:371-385, 1998
48. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL: Expression of hypoxia-inducible factor 1α brain tumors. Cancer 88:2606-2618, 2002
49. Zeheb R, Rafferty UM, Rodriguez MA, Andreasen P, Gelehrter TD: Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1. Thromb Haemost 58:1017-1023, 1987